LENZ Therapeutics (LENZ) Interest Coverage Ratio (2020)
LENZ Therapeutics (LENZ) reported Interest Coverage Ratio of 64.6 for Q2 2020.
LENZ Therapeutics (LENZ) has 1 years of Interest Coverage Ratio data on file, last reported at 64.6 in Q2 2020.
- Quarterly Interest Coverage Ratio changed N/A year-over-year to 64.6 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was 1137.35 (changed N/A YoY) and the FY2020 annual result came in at 337.5, changed N/A from the prior year.
- Interest Coverage Ratio steadied at 64.6 in Q2 2020 per LENZ's latest filing.
- Across five years, Interest Coverage Ratio topped out at 64.6 in Q2 2020 and bottomed at 64.6 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 11.50 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 49.84 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3.88 |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -64.60 |